Results 1 to 10 of about 9,360,292 (409)

A Systematic Review and Meta-Analysis of Anti-Rheumatic Drugs and Pneumococcal Vaccine Immunogenicity in Inflammatory Arthritis

open access: yesVaccines, 2023
Background: Pneumococcal pneumonia is an important cause of morbidity and mortality amongst patients with inflammatory arthritis. Vaccination is recommended by the National Institute for Health and Care Excellence (NICE) but it remains unclear how ...
Deepak Nagra   +12 more
doaj   +1 more source

The X in seX-biased immunity and autoimmune rheumatic disease

open access: yesJournal of Experimental Medicine, 2022
Sex differences in immune function have important implications for autoimmune disease susceptibility and prognosis. This review highlights sex differences in immune health and focuses on the genetic and epigenetic mechanisms contributing to the female ...
Nikhil Jiwrajka, M. Anguera
semanticscholar   +1 more source

Impact of SARS-CoV-2 mRNA vaccine on arthritis condition in rheumatoid arthritis

open access: yesFrontiers in Immunology, 2023
BackgroundThe SARS-CoV-2 mRNA vaccine has been reported to cause various adverse reactions, including the development or exacerbation of autoimmune diseases, but the adverse reactions and the effects of the vaccines on disease activity in patients with ...
Ayuko Takatani   +8 more
doaj   +1 more source

Rivaroxaban in Rheumatic Heart Disease-Associated Atrial Fibrillation.

open access: yesNew England Journal of Medicine, 2022
BACKGROUND Testing of factor Xa inhibitors for the prevention of cardiovascular events in patients with rheumatic heart disease-associated atrial fibrillation has been limited.
S. Connolly   +36 more
semanticscholar   +1 more source

Usefulness of position emission tomography/computed tomography in a case of sarcoidosis with multiorgan involvement

open access: yesClinical Case Reports, 2022
Sarcoidosis, a systemic inflammatory disease of unknown etiology, can affect any site in the body. A bone lesion was unexpectedly detected by fluorodeoxyglucose position emission tomography/computed tomography (FDG PET/CT) in a patient with multiorgan ...
Norihiko Amano   +3 more
doaj   +1 more source

Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry

open access: yesAnnals of the Rheumatic Diseases, 2020
Objectives COVID-19 outcomes in people with rheumatic diseases remain poorly understood. The aim was to examine demographic and clinical factors associated with COVID-19 hospitalisation status in people with rheumatic disease.
M. Gianfrancesco   +27 more
semanticscholar   +1 more source

The effects of alcohol consumption and its associations with disease activity among 979 patients with inflammatory arthritis

open access: yesRMD Open, 2021
Objective The role of alcohol in inflammatory disease remains debated. This study explores the relationship between alcohol and disease activity in patients with inflammatory arthritis.Methods Patients attending a rheumatology clinic between 2010 and ...
Phil Gallagher   +9 more
doaj   +1 more source

Clinical characteristics and outcomes of patients with coronavirus disease 2019 (COVID-19) and rheumatic disease: a comparative cohort study from a US ‘hot spot’

open access: yesAnnals of the Rheumatic Diseases, 2020
Objective To investigate differences in manifestations and outcomes of coronavirus disease 2019 (COVID-19) infection between those with and without rheumatic disease.
K. D’Silva   +8 more
semanticscholar   +1 more source

American College of Rheumatology Guidance for the Management of Rheumatic Disease in Adult Patients During the COVID‐19 Pandemic: Version 1

open access: yesArthritis & Rheumatology, 2020
To provide guidance to rheumatology providers on the management of adult rheumatic disease in the context of the coronavirus disease 2019 (COVID‐19) pandemic.
T. Mikuls   +15 more
semanticscholar   +1 more source

Disease activity and humoral response in patients with inflammatory rheumatic diseases after two doses of the Pfizer mRNA vaccine against SARS-CoV-2

open access: yesAnnals of the Rheumatic Diseases, 2021
Background The registration trials of messenger RNA (mRNA) vaccines against SARS-CoV-2 did not address patients with inflammatory rheumatic diseases (IRD).
Y. Braun-Moscovici   +8 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy